Source: International Congress 2017 – Techniques in biomarker selection
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Papathanassiou (ATHENS, Greece). Th2 related biomarkers as predictors of airway eosinophilia in optimally treated smoking asthmatics: An observational study.. 2935

Member's Comments

No comment yet.

Related content which might interest you: Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 Are asymptomatic airway hyperresponsiveness and allergy risk factors for asthma? A longitudinal study Source: Eur Respir J 2008; 32: 70-76 Year: 2008 Airway hyperresponsiveness and smoking, but not atopy, are associated with moderate and severe-persistent respiratory disease: analysis of a longitudinal birth cohort Source: Annual Congress 2005 - Highlights of asthma epidemiology Year: 2005 CD8+ve airway inflammation in COPD: The impact of smoking status Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work Year: 2003 Surrogate markers of airway inflammation are not increased in actively smoking mild to moderate asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 283s Year: 2001 Are asymptomatic airway hyperresponsiveness and allergy risk factors for asthma? A longitudinal study Source: Eur Respir J 2009; 33: 218-219 Year: 2009 Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial Source: Eur Respir J 2007; 30: 457-466 Year: 2007 The association between airway hyperresponsiveness to mannitol and T2 inflammatory markers in asthma versus COPD Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Inflammatory cytokines in serum from children with severe asthma compared to controlled asthmatics Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy Year: 2012 Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Th-17 cytokine profile in a Greek asthmatic population. Correlation with asthma severity and biomarkers of inflammation. Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Evolution of asthma in relation to the bronchial inflammatory phenotype: a follow-up study Source: International Congress 2018 – Asthma analysis Year: 2018 Longitudinal measurement of airway inflammation relates to a higher risk of exacerbation in COPD. Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Comparison of airway T cell phenotypes in COPD and severe asthma: the influence of smoking Source: Eur Respir J 2005; 26: Suppl. 49, 23s Year: 2005 Subjects in a population study with high levels of FENO have associated eosinophil airway inflammation in BAL Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004 Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Relationships between lung physiology and airway and systemic inflammation: a cohort study in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 The effect of statin usage on airway inflammatiory cells and markers, and clinical indices in asthmatic patients Source: Annual Congress 2011 - Asthma management and response Year: 2011 An increase in bronchial responsiveness is associated with continuing or restarting smoking Source: Annual Congress 2005 - Highlights of asthma epidemiology Year: 2005 Associations of serum cytokine levels with asthma, wheeze and allergic rhinitis symptoms in 5-years old children: a population-based study Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020